| 74 pregnant women (1.4%) with positive Prisca risk calculation and postulated marked changes in biochemical markers and/or US
During a one-year evaluation period among 5257 pregnant women |
| Prenatally confirmed genetic or structural abnormality |
12 cases (16.2%) |
| Fetal death |
12 cases (16.2%) |
| Postnatally confirmed genetic or structural abnormality |
4 cases (5.4%) |
| Healthy child at the age of 2 years |
31 cases (41.9%) |
| Lost during prenatal or postnatal evaluation |
15 cases (20.3%) |
